8-K: Health Catalyst to Acquire Upfront Healthcare, Announces Preliminary 2024 Results and 2025 Targets

Health Catalyst has announced a definitive agreement to acquire Upfront Healthcare, along with preliminary 2024 financial results and forward-looking targets for 2025.

Summary

• Health Catalyst has entered into a merger agreement to acquire Upfront Healthcare for approximately $86 million, net of cash on hand, plus a potential earn-out of $33.4 million based on performance targets by December 31, 2026.
• The acquisition is expected to close in the first quarter of 2025 and will be funded through a mix of cash and stock.
• The preliminary 2024 results show revenue between $305.7 million and $306.7 million, a 3% increase year-over-year, with technology revenue between $194.0 million and $195.0 million, a 4% increase.
• Adjusted EBITDA for 2024 is estimated at $26.1 million, a 9% margin, with the technology business unit achieving $25 million and a 13% margin.
• Health Catalyst added 21 net new platform clients in 2024, a 91% increase, and now has over 1,000 platform and app clients.
• The company's dollar-based retention rate is 102% using the updated definition including Technology and Technology Enabled Managed Services (TEMS).
• For 2025, Health Catalyst projects revenue of approximately $335 million, a 10% increase, with technology revenue of approximately $220 million, a 13% increase.
• Adjusted EBITDA for 2025 is targeted at approximately $39 million, a 12% margin, with the technology business unit targeting $38 million and a 17% margin.
• The company aims to add approximately 40 net new platform clients in 2025 and achieve a dollar-based retention rate of approximately 103% using the updated definition.
• Health Catalyst has decided to exit its unprofitable pilot Ambulatory Operations TEMS offering by mid-2025, which represents approximately $9 million in annual services revenue.

Sentiment

Score: 7

Explanation: The document presents a positive outlook with a strategic acquisition and strong growth targets, but also acknowledges some challenges and risks. The sentiment is generally optimistic but tempered by the need for successful integration and execution.

Positives

• The acquisition of Upfront Healthcare is expected to strengthen Health Catalyst's patient activation offering.
• The company's 2024 Adjusted EBITDA exceeded the midpoint of the previously provided range.
• Health Catalyst experienced a significant increase in net new platform clients in 2024, up 91%.
• The company's dollar-based retention rate remains strong at 102% using the updated definition.
• The 2025 revenue and Adjusted EBITDA targets show strong growth projections.
• The technology business unit is expected to achieve a Rule of 30 profile in 2025.

Negatives

• The company experienced a few minor project delays in Q4 2024.
• The company is exiting its unprofitable pilot Ambulatory Operations TEMS offering, which will reduce annual services revenue by approximately $9 million.
• The average ARR plus non-recurring revenue from new platform clients was towards the lower end of the $400k to $1M range.

Risks

• The acquisition of Upfront Healthcare is subject to customary closing conditions, including regulatory approvals.
• The integration of Upfront Healthcare into Health Catalyst's portfolio may present challenges.
• The company's actual results may differ materially from the preliminary estimates and forward-looking targets.
• The company's financial performance is subject to various risks and uncertainties, including changes in market conditions and regulatory environments.
• The company's ability to achieve its growth targets depends on its ability to recruit and retain qualified team members.

Future Outlook

Health Catalyst anticipates continued growth in 2025, driven by the acquisition of Upfront Healthcare and expansion of its platform and client base. The company aims to achieve a Rule of 30 profile for its technology business unit in 2025 and a Rule of 40 profile by 2028.

Management Comments

• Health Catalyst CEO Dan Burton stated that the company is excited to welcome the Upfront team and combine their mission-driven mindsets and patient experience capabilities.
• Ben Albert, CEO and co-founder at Upfront, said they are thrilled to join the Health Catalyst family and aim to better serve healthcare organizations in transforming the patient experience.
• Dave Ross, Chief Technology Officer, stated that they are using generative AI to increase the efficiency and overall business success of specific human capital-intensive tasks.

Industry Context

The acquisition of Upfront Healthcare aligns with the industry trend of healthcare providers seeking to improve patient engagement and access through digital platforms. Health Catalyst is positioning itself to capitalize on this trend by integrating Upfront's technology into its existing offerings.

Comparison to Industry Standards

• Health Catalyst's dollar-based retention rate of 102% is strong compared to industry averages for SaaS companies, which typically range from 90% to 110%.
• The company's projected revenue growth of 10% for 2025 is solid, but not exceptional, compared to some high-growth SaaS companies in the healthcare space.
• The targeted Adjusted EBITDA margin of 12% for 2025 is a significant improvement from the 9% in 2024, indicating a move towards profitability.
• Companies like Veeva Systems and Cerner, while operating in different segments of healthcare technology, serve as benchmarks for growth and profitability in the healthcare IT sector.
• Health Catalyst's focus on data and analytics aligns with the broader industry trend of leveraging data to improve healthcare outcomes and reduce costs, similar to companies like Optum and IBM Watson Health.

Stakeholder Impact

• Shareholders will be impacted by the acquisition of Upfront Healthcare and the issuance of new shares.
• Employees of both Health Catalyst and Upfront Healthcare will be affected by the integration process.
• Customers of both companies will benefit from the combined offerings and improved patient engagement capabilities.
• Suppliers and creditors may be impacted by the changes in the company's operations and financial structure.

Next Steps

• The company will work to close the acquisition of Upfront Healthcare in Q1 2025.
• Health Catalyst will focus on integrating Upfront's technology into its existing platform.
• The company will continue to execute its growth strategy and work towards achieving its 2025 targets.
• Health Catalyst will complete its year-end close and review procedures for 2024.

Key Dates

Keywords

healthcare analytics, patient engagement, data platform, acquisitions, financial results, EBITDA, revenue, technology, SaaS, digital health